Jeffrey M. Dayno, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jeffrey M. Dayno, M.D.
Jeffrey M. Dayno, M.D. is recorded as Board Member and CEO at Harmony Biosciences Holdings, Inc. (HRMY). Harmony Biosciences Holdings, Inc. reported in an 8-K filed April 24, 2023 that Jeffrey M. Dayno, M.D. was appointed member of the Board. Harmony Biosciences Holdings, Inc. reported in an 8-K filed April 24, 2023 that Jeffrey M. Dayno, M.D. was appointed President and Chief Executive Officer.
“has been elected to join as a member of the Board.”
“Jeffrey M. Dayno, M.D., has been appointed President and Chief Executive Officer by the Company's Board of Directors”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-04-24–present
-
Current
2023-04-24–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Harmony Biosciences Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- Jeffrey Dayno CEO
- Jeffrey M. Dayno CEO, Board Member
- Jeffrey S. Aronin Chairman
- Glenn Reicin CFO
- Sandip Kapadia CFO
- Susan Drexler CFO
- Peter Anastasiou COO, Board Member
- Eric Motley Board Member
- Linda Szyper Board Member
- Mark Graf Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.